From Molecule to Patient: A Biotech Perspective
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Wiley
2021
|
Online Access: | https://hdl.handle.net/1721.1/136560.2 |
_version_ | 1811091740425191424 |
---|---|
author | Langer, Robert S Jaklenec, Ana Traverso, Carlo Giovanni Hartman, Daniel |
author2 | Koch Institute for Integrative Cancer Research at MIT |
author_facet | Koch Institute for Integrative Cancer Research at MIT Langer, Robert S Jaklenec, Ana Traverso, Carlo Giovanni Hartman, Daniel |
author_sort | Langer, Robert S |
collection | MIT |
first_indexed | 2024-09-23T15:07:16Z |
format | Article |
id | mit-1721.1/136560.2 |
institution | Massachusetts Institute of Technology |
language | English |
last_indexed | 2024-09-23T15:07:16Z |
publishDate | 2021 |
publisher | Wiley |
record_format | dspace |
spelling | mit-1721.1/136560.22021-11-30T16:41:53Z From Molecule to Patient: A Biotech Perspective Langer, Robert S Jaklenec, Ana Traverso, Carlo Giovanni Hartman, Daniel Koch Institute for Integrative Cancer Research at MIT Massachusetts Institute of Technology. Department of Mechanical Engineering 2021-11-30T16:41:52Z 2021-10-27T20:35:58Z 2021-11-30T16:41:52Z 2020 2021-06-22T14:12:14Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/136560.2 en http://dx.doi.org/10.1002/CPT.1676 Clinical Pharmacology and Therapeutics Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/octet-stream Wiley Wiley |
spellingShingle | Langer, Robert S Jaklenec, Ana Traverso, Carlo Giovanni Hartman, Daniel From Molecule to Patient: A Biotech Perspective |
title | From Molecule to Patient: A Biotech Perspective |
title_full | From Molecule to Patient: A Biotech Perspective |
title_fullStr | From Molecule to Patient: A Biotech Perspective |
title_full_unstemmed | From Molecule to Patient: A Biotech Perspective |
title_short | From Molecule to Patient: A Biotech Perspective |
title_sort | from molecule to patient a biotech perspective |
url | https://hdl.handle.net/1721.1/136560.2 |
work_keys_str_mv | AT langerroberts frommoleculetopatientabiotechperspective AT jaklenecana frommoleculetopatientabiotechperspective AT traversocarlogiovanni frommoleculetopatientabiotechperspective AT hartmandaniel frommoleculetopatientabiotechperspective |